Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV

References

• Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov 8;367(19):1814–1820.
   PubMed Web of Science ®Google Scholar
• Organization WH. Middle East respiratory syndrome coronavirus (MERS-CoV). [cited 2019 Oct 15]. Available from: http://www.who.int/emergencies/mers-cov/en/
   Google Scholar
• Haagmans BL, Al Dhahiry SH, Reusken CB, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014 Feb;14(2):140–145.
   PubMed Web of Science ®Google Scholar
• Organization WH. R&D Blueprint: List of Blueprint priority diseases. [cited 2019 May 20]. Available from: https://www.who.int/blueprint/priority-diseases/en/
   Google Scholar
• Okba NM, Raj VS, Haagmans BL. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol. 2017 Apr;23:49–58.
   PubMed Web of Science ®Google Scholar
• Huber VC. Influenza vaccines: from whole virus preparations to recombinant protein technology. Expert Rev Vaccines. 2014 Jan;13(1):31–42.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Chen JY, Chen HW, et al. Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation. Nanotheranostics. 2017;1(3):244–260.
   PubMedGoogle Scholar
• Brune KD, Leneghan DB, Brian IJ, et al. Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization. Sci Rep. 2016 Jan 19;6:19234.
   PubMed Web of Science ®Google Scholar
• Wilson JT. A sweeter approach to vaccine design. Science. 2019 Feb 8;363(6427):584–585.
   PubMed Web of Science ®Google Scholar
• Tokatlian T, Read BJ, Jones CA, et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science. 2019 Feb 8;363(6427):649–654.
   PubMed Web of Science ®Google Scholar
• Marcandalli J, Fiala B, Ols S, et al. Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus. Cell. 2019 Mar 7;176(6):1420–1431.e17.
   PubMed Web of Science ®Google Scholar
• Lopez-Sagaseta J, Malito E, Rappuoli R, et al. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J. 2016;14:58–68.
   PubMed Web of Science ®Google Scholar
• Jardine J, Julien JP, Menis S, et al. Rational HIV immunogen design to target specific germline B cell receptors. Science. 2013 May 10;340(6133):711–716.
   PubMed Web of Science ®Google Scholar
• Hsia Y, Bale JB, Gonen S, et al. Design of a hyperstable 60-subunit protein dodecahedron. [corrected]. Nature. 2016 Jul 7;535(7610):136–139.
   PubMed Web of Science ®Google Scholar
• Bruun TUJ, Andersson AC, Draper SJ, et al. Engineering a rugged nanoscaffold to enhance plug-and-display vaccination. ACS Nano. 2018 Sep 25;12(9):8855–8866.
   PubMed Web of Science ®Google Scholar
• Brune KD, Howarth M. New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue. Front Immunol. 2018;9:1432.
   PubMed Web of Science ®Google Scholar
• Li W, Hulswit RJG, Widjaja I, et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci U.S.A. 2017 Oct 3;114(40):E8508–E8517.
   PubMed Web of Science ®Google Scholar
• Mou H, Raj VS, van Kuppeveld FJ, et al. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013 Aug;87(16):9379–9383.
   PubMed Web of Science ®Google Scholar
• Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067.
   PubMed Web of Science ®Google Scholar
• Widjaja I, Wang C, van Haperen R, et al. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microbes Infect. 2019 Jan 1;8(1):516–530.
   PubMed Web of Science ®Google Scholar
• Wang L, Shi W, Chappell JD, et al. Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape. J Virol. 2018 May 15;92(10):e02002-17.
   PubMed Web of Science ®Google Scholar
• Lei Y, Zhao F, Shao J, et al. Application of built-in adjuvants for epitope-based vaccines. PeerJ. 2019;6:e6185.
   PubMed Web of Science ®Google Scholar
• Li L, Fierer JO, Rapoport TA, et al. Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag. J Mol Biol. 2014 Jan 23;426(2):309–317.
   PubMed Web of Science ®Google Scholar
• Widagdo W, Okba NMA, Richard M, et al. Lack of Middle East respiratory syndrome coronavirus transmission in rabbits. Viruses. 2019 Apr 24;11(4):381.
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010 Nov;10(11):787–796.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Y, Huang J, et al. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019 Jan 14;11(1):60.
   PubMed Web of Science ®Google Scholar
• Kim YS, Son A, Kim J, et al. Chaperna-mediated assembly of ferritin-based Middle East respiratory syndrome-coronavirus nanoparticles. Front Immunol. 2018;9:1093.
   PubMed Web of Science ®Google Scholar
• Daniel C, Anderson R, Buchmeier MJ, et al. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J Virol. 1993 Mar;67(3):1185–1194.
   PubMed Web of Science ®Google Scholar
• Routledge E, Stauber R, Pfleiderer M, et al. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J Virol. 1991 Jan;65(1):254–262.
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Coughlin MM, Baker SC, et al. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PloS one. 2012;7(11):e50366.
   PubMed Web of Science ®Google Scholar
• Lai SC, Chong PC, Yeh CT, et al. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV). J Biomed Sci. 2005 Oct;12(5):711–727.
   PubMed Web of Science ®Google Scholar
• Lip KM, Shen S, Yang X, et al. Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus. J Virol. 2006 Jan;80(2):941–950.
   PubMed Web of Science ®Google Scholar
• Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods. 1986 Jan 22;86(1):83–87.
   PubMed Web of Science ®Google Scholar
• Haagmans BL, van den Brand JM, Provacia LB, et al. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J Virol. 2015 Jun;89(11):6131–6135.
   PubMed Web of Science ®Google Scholar
• Houser KV, Broadbent AJ, Gretebeck L, et al. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLoS Pathog. 2017 Aug;13(8):e1006565.
   PubMed Web of Science ®Google Scholar
• Leneghan DB, Miura K, Taylor IJ, et al. Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. Sci Rep. 2017 Jun 19;7(1):3811.
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng X, Gai W, et al. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antiviral Res. 2017 Apr;140:55–61.
   PubMed Web of Science ®Google Scholar
• Kanekiyo M, Wei CJ, Yassine HM, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013 Jul 4;499(7456):102–106.
   PubMed Web of Science ®Google Scholar
• Falzarano D, de Wit E, Feldmann F, et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014 Aug;10(8):e1004250.
   PubMed Web of Science ®Google Scholar
• Modjarrad K, Moorthy VS, Ben Embarek P, et al. A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation. Nat Med. 2016 Jul 7;22(7):701–705.
   PubMed Web of Science ®Google Scholar